Related Experiment Video
Updated: Jun 29, 2026

Technical Demonstration of Whole Genome Array Comparative Genomic Hybridization
Published on: August 5, 2008
Integrated sequencing and array comparative genomic hybridization in familial Parkinson disease
Laurie A Robak1, Renqian Du1, Bo Yuan1
1Department of Molecular and Human Genetics (L.A.R., R.D., B.Y., S.G., V.K., E.H., A.S., E.Y., C.Z., X.S., H.D., T.G., Z.C.A., A.T., C.S., W.B., J.E.P., J.R.L., J.M.S.), Department of Neurology (I.A.-D., J.J., J.M.S.), and Human Genome Sequencing Center (S.N.J., D.M.M., J.R.L.), Baylor College of Medicine, Houston, TX; Baylor Genetics (W.B.), Houston, TX; Department of Neurology (O.A.R.), Department of Neuroscience (O.A.R.), and Department of Clinical Genomics (O.A.R.), Mayo Clinic, Jacksonville, FL; Parkinson's Disease Center and Movement Disorders Clinic (J.J.) and Department of Pediatrics (J.R.L., J.M.S.), Baylor College of Medicine, Houston, TX; Department of Pediatrics (J.R.L.), Texas Children's Hospital, Houston; Department of Neuroscience (J.M.S.), Baylor College of Medicine, Houston, TX; and Jan and Dan Duncan Neurological Research Institute (J.M.S.), Texas Children's Hospital, Houston.
This study integrated exome sequencing and array comparative genomic hybridization to diagnose familial Parkinson disease (PD). The combined approach identified genetic variants, including single nucleotide variants and copy number variants, leading to a molecular diagnosis in 19.3% of familial PD cases.
Area of Science:
- Genetics
- Neurodegenerative Diseases
- Molecular Biology
Background:
- Familial Parkinson disease (PD) presents complex genetic heterogeneity.
- Distinguishing the roles of single nucleotide variants (SNVs) and copy number variants (CNVs) is crucial for molecular diagnosis.
- Integrated genomic approaches are needed to fully characterize genetic contributions to PD.
Purpose of the Study:
- To determine the contribution of SNVs and CNVs to molecular diagnosis in familial Parkinson disease (PD).
- To integrate exome sequencing (ES) and array-based comparative genomic hybridization (aCGH) for comprehensive genetic analysis.
- To investigate CNV structure and elucidate mutational mechanisms in PD.
Main Methods:
- Performed exome sequencing (ES) on 110 subjects with familial PD.
- Utilized genome-wide array-based comparative genomic hybridization (aCGH) in 99 subjects.
- Interrogated ES and aCGH data for pathogenic SNVs and CNVs at known PD gene loci, confirmed with Sanger sequencing, droplet digital PCR, and breakpoint sequencing.
Main Results:
- Identified known pathogenic SNVs in GBA and LRRK2 genes.
- Discovered SNCA duplication and GBA deletion via aCGH.
- Found compound heterozygosity for SNVs and CNVs at the PRKN locus in five subjects, with microhomology indicating replication error-driven CNV formation.
Conclusions:
- Integrated ES and aCGH achieved a genetic diagnosis in 19.3% of the familial PD cohort.
- Highlighted potential mechanisms for SNCA and PRKN CNV formation.
- Uncovered multilocus pathogenic variation and identified novel SNVs and CNVs for future PD risk allele investigation.
More Related Videos
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology

